Package Leaflet: Information for the User
Cefuroxime Cinfa 500 mg Film-Coated Tablets
Cefuroxime (as axetil)
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and additional information.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold.
It is essential to follow the instructions regarding the dose, administration interval and treatment duration indicated by your doctor.
Do not store or reuse this medication. If you have leftover antibiotic after treatment, return it to the pharmacy for proper disposal. Do not throw away medications in the drain or trash.
Cefuroxima is used to treat infections of:
Cefuroxima may also be used to:
Your doctor may analyze the type of bacteria causing your infection and check if the bacteria are sensitive to cefuroxima during treatment.
Do not take cefuroxima cinfa
If you think this applies to you,do not take cefuroximauntil you have consulted your doctor.
Be especially careful with cefuroxima cinfa
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been associated with cefuroxima treatment. Seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Warnings and precautions
Consult your doctor or pharmacist before starting to take cefuroxima cinfa.
Children
Cefuroxima is not recommended for children under 3 months, as its safety and efficacy for this age group are unknown.
You should be aware of certain symptoms such as allergic reactions, fungal infections (such asCandida), and severe diarrhea (pseudomembranous colitis) while taking cefuroxima. This will reduce the risk of potential complications. See“Symptoms to be aware of”in section 4.
If you need a blood test
Cefuroxima may affect the results of blood sugar levels or theCoombs test.
If you need a blood test:
Other medicines and cefuroxima cinfa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Medicines used toreduce stomach acid(e.g.antacidsfor treatingheartburn) may affect the mechanism of action of cefuroxima.
Probenecid
Oral anticoagulants.
Birth control pill
Cefuroxima may reduce the effectiveness of the birth control pill. If you are taking the birth control pill while taking cefuroxima, you should use additional barrier methods (such ascondoms). Consult your doctor.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and operating machinery
Cefuroximamay cause dizzinessand other adverse effects that may impair your ability to be alert.
Cefuroxima cinfa contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Take cefuroxime after meals.This will help make the treatment more effective. Swallow the cefuroxime tablets whole with water.
Do not chew, crush or divide the tablets -this may make the treatment less effective.
Recommended dose
Adults
The recommended dose of cefuroxime is 250 mg to 500 mg twice a day, depending on the severity and type of infection.
Children
The recommended dose of cefuroxime is 10 mg/kg of the child's weight (up to a maximum of 125 mg) to 15 mg/kg of the child's weight (up to a maximum of 250 mg) twice a day, depending on:
Cefuroxime is not recommended in children under 3 months, as the safety and efficacy for this group of patients is unknown.
Depending on the disease and how you or your child responds to treatment, the initial dose may be adjusted or it may be necessary to administer more than one treatment cycle.
Patients with kidney problems
If you have kidney problems, your doctor may change your dose.
If you take more cefuroxime than you should
If you take too much cefuroxime, you may experience neurological disturbances, particularly you may have a higher probability of havingseizures (epileptic attacks).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service at telephone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to takecefuroxime
Do not take a double dose to compensate for the missed doses.Simply continue with the next dose as recommended.
If you interrupt the treatment withcefuroxime
Do not interrupt the treatment with cefuroxime without prior advice.
It is essential that you complete the entire cefuroxime treatment.Do not interrupt it unless your doctor tells you to, even if you have started to feel better. If you do not complete the treatment cycle, the infection may recur.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Symptoms you should be aware of
A small number of people who took cefuroxime presented an allergic reaction or a potentially severe skin reaction. The symptoms of these reactions include:
Other symptoms you should be aware of while taking cefuroxime
Frequent side effects
May affectup to 1 in 10patients:
Frequent side effects that may appear in blood tests:
Rare side effects
May affectup to 1 in 100patients:
Rare side effects that may appear in blood tests:
Other side effects
Other side effects have occurred in a very small number of people, but their exact frequency is unknown:
Side effects that may appear in blood tests:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special conditions for conservation.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofcefuroxima cinfa
-The other components are:
Core:pregelatinized cornstarch, sodium croscarmellose, sodium lauryl sulfate, microcrystalline cellulose, anhydrous colloidal silica, hydrogenated vegetable oil.
Coating:hypromellose (E-464), titanium dioxide (E-171), propylene glycol (E-1520), brilliant blue FCF (E-133) and indigo carmine (E-132).
Appearance of the product and contents of the package
Tablets with a clear blue film coating, in capsule shape, marked with "500" on one face and "P126" on the other face.
Presented in PVC/aluminum blisters.
Each package contains10, 15, 20 or 500 (clinical package)film-coated tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Cinfa Laboratories, S.A.
Olaz-Chipi, 10. Industrial Estate Areta
31620 Huarte (Navarra) - Spain
Responsible manufacturer
Farmalider, S.A
Aragoneses, 2
28108 (Alcobendas) Madrid
or
Toll Manufacturing Services, S.L.
C/ Aragoneses, 2
28108 – Alcobendas (Madrid)
or
Laboratorios Atral, S.A.
Rua da Estação, 1 e 1A,
Castanheira do Ribatejo, 2600-726, Portugal
Last review date of this leaflet:May 2023
For detailed information about this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/72261/P_72261.html
QR code to:https://cima.aemps.es/cima/dochtml/p/72261/P_72261.html
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.